• Info
  • Insider Ownership

Insider Trading & Ownership of Ronald C. Renaud JR

Location
Cambridge, MA
Summary
The estimated net worth of Ronald C. Renaud JR is at least $12.3K dollars as of 12 Jun 2025. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3K.
Signature
/s/ Allison Ambrose, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Ronald C. Renaud JR files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Ronald C. Renaud JR

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATRA Atara Biotherapeutics, Inc. Director $12.3K 23 Jun 2022
CERE Cerevel Therapeutics Holdings, Inc. President & CEO, Director $0 01 Aug 2024
IKNA Ikena Oncology, Inc. Director 09 Jun 2022
TBIO Translate Bio, Inc. Chief Executive Officer, Director 14 Sep 2021
UPB Upstream Bio, Inc. Director 10 Jun 2025

Insider Transactions Reported by Ronald C. Renaud JR:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.